Capricor Therapeutics, Inc. (CAPR) Financials

CAPR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 326.3 million 47.6 million
Dec. 31, 2025 355.9 million 50.2 million
Sept. 30, 2025 126.4 million 42.6 million
June 30, 2025 133.6 million 28.6 million

CAPR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -40.0 million 5.9 million
Dec. 31, 2025 -28.7 million -3.4 billion
Sept. 30, 2025 -23.7 million 7.4 billion
June 30, 2025 -21.6 million 3.6 million

CAPR Net Income

No data available :(

CAPR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 278.6 million - 13.9 million
Dec. 31, 2025 318.1 million - 14.5 million
Sept. 30, 2025 98.6 million - 14.5 million
June 30, 2025 122.8 million - 1.0 million

CAPR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 57.4 million
Dec. 31, 2025 48.9 million
Sept. 30, 2025 45.7 million
June 30, 2025 45.7 million

CAPR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 10.7 million 27.4 million 9.4 million -
Dec. 31, 2025 5.1 million 23.1 million 6.0 million -
Sept. 30, 2025 4.0 million 20.4 million 5.9 million -
June 30, 2025 1.4 million 22.0 million 5.7 million -

CAPR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - 20.4 million
June 30, 2025 - 22.0 million

CAPR

Price: $26.72

52 week price:
4.30
40.37

Earnings Per Share: -2.32 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 60100

Ebitda: -2.6 million

Market Capitalization: 1.2 billion

Links: